Nicotine Inhibits Memory CTL Programming

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sun, Zhifeng ^a   Smyth, Kendra ^a   Garcia, Karla ^a   Mattson, Elliot ^a   Li, Lei ^a   Xiao, Zhengguo ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; NICOTINE; NICOTINIC RECEPTOR; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, TRANSGENIC; NICOTINE; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIROLIMUS; T-LYMPHOCYTES, CYTOTOXIC;

MUS; NICOTIANA TABACUM;

EID: 84879740532     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068183     Document Type: Article

References (83)

1. Tuesta LM, Fowler CD, Kenny PJ, (2011) Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 82(8): 984-995.
2. Tournier JM, Birembaut P, (2011) Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr Opin Oncol 23: 83-87.
3. Tammimaki A, Horton WJ, Stitzel JA, (2011) Recent advances in gene manipulation and nicotinic acetylcholine receptor biology. Biochem Pharmacol 82: 808-819.
4. Miwa JM, Freedman R, Lester HA, (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70: 20-33.
5. Govind AP, Vezina P, Green WN, (2009) Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol 78: 756-765.
6. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW, (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89: 73-120.
7. Benowitz NL, (2011) Smokeless tobacco as a nicotine delivery device: harm or harm reduction? Clin Pharmacol Ther 90: 491-493.
8. Rodu B, (2011) The scientific foundation for tobacco harm reduction, 2006-2011. Harm Reduct J 8: 19.
9. Harty JT, Badovinac VP, (2008) Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 8: 107-119.
10. Kaech SM, Wherry EJ, Ahmed R, (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
11. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, et al. (2006) Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211: 81-92.
12. Wakim LM, Bevan MJ, (2010) From the thymus to longevity in the periphery. Curr Opin Immunol 22: 274-278.
13. Way SS, Havenar-Daughton C, Kolumam GA, Orgun NN, Murali-Krishna K, (2007) IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection. J Immunol 178: 4498-4505.
14. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, et al. (2006) CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol 176: 4525-4529.
15. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.
16. Li Q, Eppolito C, Odunsi K, Shrikant PA, (2006) IL-12-programmed long-term CD8+ T cell responses require STAT4. J Immunol 177: 7618-7625.
17. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF, (2005) Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 174: 4465-4469.
18. Curtsinger JM, Lins DC, Mescher MF, (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 197: 1141-1151.
19. Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, et al. (1999) Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162: 3256-3262.
20. Curtsinger JM, Lins DC, Mescher MF, (1998) CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol 160: 3236-3243.
21. Schmidt CS, Mescher MF, (1999) Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. J Immunol 163: 2561-2567.
22. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF, (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182: 2786-2794.
23. Curtsinger JM, Johnson CM, Mescher MF, (2003) CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171: 5165-5171.
24. Rao RR, Li Q, Odunsi K, Shrikant PA, (2010) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32: 67-78.
25. Li X, Garcia K, Sun Z, Xiao Z, (2011) Temporal Regulation of Rapamycin on Memory CTL Programming by IL-12. PLoS ONE 6: e25177.
26. Powell JD, Delgoffe GM, (2010) The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33: 301-311.
27. Thomson AW, Turnquist HR, Raimondi G, (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
28. De Biasi M, Dani JA, (2011) Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 34: 105-130.
29. Buckingham SD, Jones AK, Brown LA, Sattelle DB, (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61: 39-61.
30. De Rosa MJ, Esandi Mdel C, Garelli A, Rayes D, Bouzat C, (2005) Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol 160: 154-161.
31. Gahring LC, Osborne-Hereford AV, Vasquez-Opazo GA, Rogers SW, (2008) Tumor necrosis factor alpha enhances nicotinic receptor up-regulation via a p38MAPK-dependent pathway. J Biol Chem 283: 693-699.
32. Kawashima K, Fujii T, (2003) The lymphocytic cholinergic system and its biological function. Life Sci 72: 2101-2109.
33. Peng H, Ferris RL, Matthews T, Hiel H, Lopez-Albaitero A, et al. (2004) Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes. Life Sci 76: 263-280.
34. Qian J, Galitovskiy V, Chernyavsky AI, Marchenko S, Grando SA, (2011) Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun 12: 222-230.
35. Xiao Z, Mescher MF, Jameson SC, (2007) Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J Exp Med 204: 2667-2677.
36. Al-Wadei HA, Plummer HK 3rd, Schuller HM (2009) Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis 30: 506-511.
37. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, et al. (1998) Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 38: 502-509.
38. Ozger Ilhan S, Sarioglu Y, Vural IM, Dilekoz E, Ozturk GS, et al. (2008) Hydrogen peroxide and antioxidizing enzymes involved in modulation of transient facilitatory effects of nicotine on neurogenic contractile responses in rat gastric fundus. Eur J Pharmacol 587: 267-272.
39. Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, et al. (2010) Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J Pharmacol Exp Ther 335: 553-561.
40. Stampfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
41. Sopori M, (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
42. Xiao Z, Curtsinger JM, Prlic M, Jameson SC, Mescher MF, (2007) The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. Int Immunol 19: 733-743.
43. Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, et al. (2005) Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6: 1236-1244.
44. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
45. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, et al. (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295: 338-342.
46. Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL, (2006) Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol 177: 7515-7519.
47. Balendran A, Currie R, Armstrong CG, Avruch J, Alessi DR, (1999) Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J Biol Chem 274: 37400-37406.
48. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, et al. (1998) Phosphorylation and activation of p70s6k by PDK1. Science 279: 707-710.
49. Burgering BM, Coffer PJ, (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
50. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: 513-521.
51. Song J, Salek-Ardakani S, So T, Croft M, (2007) The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nat Immunol 8: 64-73.
52. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126: 955-968.
53. Djordjevic MV, Doran KA (2009) Nicotine content and delivery across tobacco products. Handb Exp Pharmacol: 61-82.
54. Scott DA, Martin M, (2006) Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. World J Gastroenterol 12: 7451-7459.
55. Ulloa L, (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4: 673-684.
56. Dajas-Bailador F, Wonnacott S, (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25: 317-324.
57. Sopori ML, Kozak W, (1998) Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83: 148-156.
58. Ahmed R, Bevan MJ, Reiner SL, Fearon DT, (2009) The precursors of memory: models and controversies. Nat Rev Immunol 9: 662-668.
59. Jameson SC, Masopust D, (2009) Diversity in T cell memory: an embarrassment of riches. Immunity 31: 859-871.
60. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, et al. (1998) CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 822-826.
61. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, et al. (1999) CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 711-717.
62. Traves SL, Smith SJ, Barnes PJ, Donnelly LE, (2004) Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol 76: 441-450.
63. Agarwal P, Raghavan A, Nandiwada SL, Curtsinger JM, Bohjanen PR, et al. (2009) Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 183: 1695-1704.
64. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, et al. (2009) Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31: 296-308.
65. Intlekofer AM, Takemoto N, Kao C, Banerjee A, Schambach F, et al. (2007) Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med 204: 2015-2021.
66. Cannarile MA, Lind NA, Rivera R, Sheridan AD, Camfield KA, et al. (2006) Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat Immunol 7: 1317-1325.
67. Ichii H, Sakamoto A, Hatano M, Okada S, Toyama H, et al. (2002) Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat Immunol 3: 558-563.
68. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205: 625-640.
69. Rutishauser RL, Kaech SM, (2010) Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation. Immunol Rev 235: 219-233.
70. Wirth TC, Xue HH, Rai D, Sabel JT, Bair T, et al. (2010) Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33: 128-140.
71. Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM, (2011) An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35: 792-805.
72. Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA, (2012) Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity 36: 374-387.
73. Sullivan JA, Kim EH, Plisch EH, Peng SL, Suresh M, (2012) FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms. PLoS Pathog 8: e1002533.
74. Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, et al. (2009) Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29: 12428-12439.
75. Gentry CL, Lukas RJ, (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1: 359-385.
76. Kavoussi B, Ross BE, (2007) The neuroimmune basis of anti-inflammatory acupuncture. Integr Cancer Ther 6: 251-257.
77. Levite M, (2008) Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 8: 460-471.
78. Levite M, (2000) Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann N Y Acad Sci 917: 307-321.
79. Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, et al. (1999) Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266: 17-20.
80. Lewis RS, (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19: 497-521.
81. Manicassamy S, Gupta S, Sun Z, (2006) Selective function of PKC-theta in T cells. Cell Mol Immunol 3: 263-270.
82. Hogquist K, Jameson S, Heath W, Howard J, Bevan M, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
83. Basu S, Stuckler D, Bitton A, Glantz SA (2011) Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis. BMJ 343.